Clinical trial
Magnesium Supplements In The Treatment Of Pseudoxanthoma Elasticum (PXE)
NCT01525875 is registered in ClinicalTrials.gov with Mark Lebwohl as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Magnesium Supplements In The Treatment Of Pseudoxanthoma Elasticum (PXE)
- Lead sponsor
- Mark Lebwohl
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2012
- Completion date
- March 31, 2015
- Enrollment
- 44 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.